Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06240143 |
Title | Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (MARIANE) |
Acronym | MARIANE |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | The Netherlands Cancer Institute |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | NLD |